Stockscreener 앱 받기
82.48
0.39%
-0.3424
전일 마감가:
$82.82
열려 있는:
$82.17
하루 거래량:
435.20K
Relative Volume:
0.19
시가총액:
$15.96B
수익:
$8.41B
순이익/손실:
$760.80M
주가수익비율:
21.42
EPS:
3.8513
순현금흐름:
$1.05B
1주 성능:
-3.52%
1개월 성능:
+3.03%
6개월 성능:
-15.41%
1년 성능:
-11.62%
1일 변동 폭
$81.58
$83.20
1주일 범위
$81.58
$85.68
52주 변동 폭
$79.12
$108.29
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
82.48 | 16.02B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
85.76 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.90 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
74.75 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.43 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.78 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-23 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2026-02-20 | 개시 | William Blair | Mkt Perform |
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2026-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Acquires New Shares in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Legal & General Group Plc Has $137.94 Million Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings Is Maintained at Neutral by Citigroup - Moomoo
Citigroup Has Lowered Expectations for Zimmer Biomet (NYSE:ZBH) Stock Price - MarketBeat
Goldman Sachs Adjusts PT on Zimmer Biomet to $87 From $86, Maintains Sell Rating - Moomoo
Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance UK
Citigroup Adjusts Price Target on Zimmer Biomet to $93 From $95, Maintains Neutral Rating - marketscreener.com
Zimmer Biomet 8-K Filing May 22, 2026: NYSE Registered Securities, Entity Information, and Amendment Details - Minichart
Zimmer Biomet Holdings (ZBH) Announces Results of Annual Shareho - GuruFocus
Zimmer Biomet (ZBH) investors approve board slate and pay, reject independent chair bid - Stock Titan
Declaration of Voting Results by Zimmer Biomet - marketscreener.com
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (NYSE: ZBH) director receives new RSU and phantom unit awards - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives new RSU and phantom unit grants - Stock Titan
Zimmer Biomet (NYSE: ZBH) director awarded RSU and phantom stock units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director granted Restricted and Phantom Stock Units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director granted RSUs and phantom stock units as compensation - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives stock and phantom unit awards - Stock Titan
Zimmer Biomet (ZBH) director Arthur Higgins receives new stock and phantom unit grants - Stock Titan
Zimmer Biomet (ZBH) director granted new RSUs and phantom stock awards - Stock Titan
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is Zimmer Biomet Holdings (ZBH) One of the Best Robotic Surgery Stocks to Buy? - Insider Monkey
Zimmer Biomet Holdings, Inc. $ZBH Shares Purchased by Northwestern Mutual Wealth Management Co. - MarketBeat
Cast Saw Devices Market Size Forecast & Industry Trends 2035 - SNS Insider
Zimmer Biomet’s SWOT analysis: stock faces growth headwinds By Investing.com - Investing.com Australia
Zimmer Biomet’s SWOT analysis: stock faces growth headwinds - Investing.com
Morningstar Investment Management LLC Acquires 40,610 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Promising 15% Upside with Robust Revenue Growth - DirectorsTalk Interviews
PNC Financial Services Group Inc. Raises Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) Declares Quarterly Dividend and Raises Share Repurchase Target - GuruFocus
Zimmer Biomet declares $0.24 quarterly dividend By Investing.com - Investing.com Nigeria
Zimmer Biomet declares $0.24 quarterly dividend - Investing.com UK
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 - Financial Times
Zimmer Biomet Holdings, Inc. $ZBH Stake Cut by Heritage Investors Management Corp - MarketBeat
Zimmer Biomet Holdings, Inc. Stock 12‑Month Price Target Cut to $96.45, Implies 13% Upside - TradingView
ZBH Technical Analysis | Trend, Signals & Chart Patterns | ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - ChartMill
Zimmer Biomet stock (US98956P1021): earnings and buyback update keep focus on implants - AD HOC NEWS
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Gabelli Funds LLC Boosts Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Is Zimmer Biomet’s Expanded US$1 Billion Buyback Reshaping the Investment Case for ZBH? - Sahm
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Suketu Upadhyay sells 31,253 ZBH shares (NYSE: ZBH) - Stock Titan
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Independent Advisor Alliance - MarketBeat
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock - Yahoo Finance
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now? - TradingView
Q3 2025 Zimmer Biomet Holdings Inc Earnings Call Transcript - GuruFocus
Zimmer Biomet raises share repurchase target to up to $1B by year-end - MSN
Eubel Brady & Suttman Asset Management Inc. Decreases Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Hills Bank & Trust Co Sells 14,826 Shares of Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
ZBH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why Zimmer Biomet (ZBH) Stock Is Up Today - Yahoo Finance
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.30%
자본화:
|
볼륨(24시간):